| Jackline N Ogari, | |
|
1396 108th Ave Ne, Blaine, MN 55434-3705 | |
| (763) 843-0124 | |
| Not Available |
| Full Name | Jackline N Ogari |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 1396 108th Ave Ne, Blaine, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043078090 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 2270443 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jackline N Ogari, 1396 108th Ave Ne, Blaine, MN 55434-3705 Ph: (763) 843-0124 | Jackline N Ogari, 1396 108th Ave Ne, Blaine, MN 55434-3705 Ph: (763) 843-0124 |
News Archive
Eli Lilly and Company and MacroGenics, Inc. have announced that the two companies have entered into a global strategic alliance to develop and commercialize teplizumab, a humanized anti-CD3 monoclonal antibody, as well as other potential next generation anti-CD3 molecules for use in the treatment of autoimmune diseases.
Diet exerts a major impact on health and ageing. The nervous system plays an important role in this process but, thus far, how food signals are interpreted by the nervous system has been a mystery.
Scientists have developed a new molecular sensor that can reveal the amount of zinc in cells, which could tell us more about a number of diseases, including type 2 diabetes. The research, published today in Nature Methods, opens the door to the hidden world of zinc biology by giving scientists an accurate way of measuring the concentration of zinc and its location in cells for the first time.
K-PAX Pharmaceuticals is working with Stanford University and several other leading research institutions to perform a Phase II double-blind, placebo-controlled trial to evaluate the safety and efficacy of a currently available FDA-approved medication concurrently administered with a novel mitochondrial support product in order to identify a safe and effective treatment for the chronic fatigue and decreased alertness (i.e. brain fog) that commonly afflicts people with CFS.
Newly discovered genetic variations may help predict breast cancer risk in women who receive preventive breast cancer therapy with the selective estrogen receptor modulator drugs tamoxifen and raloxifene, a Mayo Clinic-led study has found. The study is published in the journal Cancer Discovery.
› Verified 7 days ago
Mrs. Kristi Anne Sandford, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10307 University Ave Ne, Blaine, MN 55434 Phone: 763-786-3439 Fax: 763-783-3528 | |
Victoria Ashley Moeller, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3201 128th Ave Ne, Blaine, MN 55449 Phone: 763-447-9422 | |
Bao Vang, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 12630 Able Cir Ne, Blaine, MN 55434 Phone: 952-381-1474 | |
Mr. Bulli Boki, REGISTERED NURSE Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10877 Tyler Ct Ne, Blaine, MN 55434 Phone: 651-497-1811 | |
Robin Lynn Broen, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3012 129th Ave Ne, Blaine, MN 55449 Phone: -- | |
Mr. Jeremy John Beltz, R.N. Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 10307 University Ave Ne, Blaine, MN 55434 Phone: 763-786-3439 |